Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Systemic inflammatory response is a critical factor that promotes the initiation and metastasis of malignancies including pancreatic cancer (PC). This study was designed to determine and compare the prognostic value of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and fibrinogen-to-albumin ratio (FAR) in resectable PC and locally advanced or metastatic PC. Materials and Methods Three hundred fifty-three patients with resectable PC and 807 patients with locally advan-ced or metastatic PC were recruited in this study. These patients were classified into a training set (n=758) and a validation set (n=402). Kaplan-Meier survival plots and Cox proportional hazards regression models were used to analyze prognosis. Results Overall survival (OS) was significantly better for patients with resectable PC with low preoperative PLR (p=0.048) and MLR (p=0.027). Low FAR, MLR, NLR (p < 0.001), and PLR (p=0.003) were significantly associated with decreased risk of death for locally advanced or metastatic PC patients. FAR (hazard ratio [HR], 1.522; 95% confidential interval [CI], 1.261 to 1.837; p < 0.001) and MLR (HR, 1.248; 95% CI, 1.017 to 1.532; p=0.034) were independent prognostic factors for locally advanced or metastatic PC. Conclusion The prognostic roles of FAR, MLR, NLR, and PLR in resectable PC and locally advanced or metastatic PC were different. FAR showed the most prognostic power in locally advanced or metastatic PC. Low FAR was positively correlated with OS in locally advanced or metastatic PC, which could be used to predict the prognosis.
Abstract
Purpose Systemic inflammatory response is a critical factor that promotes the initiation and metastasis of malignancies including pancreatic cancer (PC). This study was designed to determine and compare the prognostic value of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and fibrinogen-to-albumin ratio (FAR) in resectable PC and locally advanced or metastatic PC. Materials and Methods Three hundred fifty-three patients with resectable PC and 807 patients with locally advan-ced or metastatic PC were recruited in this study. These patients were classified into a training set (n=758) and a validation set (n=402). Kaplan-Meier survival plots and Cox proportional hazards regression models were used to analyze prognosis. Results Overall survival (OS) was significantly better for patients with resectable PC with low preoperative PLR (p=0.048) and MLR (p=0.027). Low FAR, MLR, NLR (p < 0.001), and PLR (p=0.003) were significantly associated with decreased risk of death for locally advanced or metastatic PC patients. FAR (hazard ratio [HR], 1.522; 95% confidential interval [CI], 1.261 to 1.837; p < 0.001) and MLR (HR, 1.248; 95% CI, 1.017 to 1.532; p=0.034) were independent prognostic factors for locally advanced or metastatic PC. Conclusion The prognostic roles of FAR, MLR, NLR, and PLR in resectable PC and locally advanced or metastatic PC were different. FAR showed the most prognostic power in locally advanced or metastatic PC. Low FAR was positively correlated with OS in locally advanced or metastatic PC, which could be used to predict the prognosis.
참고문헌 (30)
- Siegel RL, "Cancer statistics, 2019", CA Cancer J Clin, 69, pp.7~34 (2019)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Witkowski ER, "Outcomes following resection of pancreatic cancer", J Surg Oncol, 107, pp.97~103 (2013)
- Cook MB, "Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma : a study within the National Cancer Institute Cohort Consortium", Gut, 68, pp.960~968 (2019)
- Coffelt SB, "Neutrophils in cancer : neutral no more", Nat Rev Cancer, 16, pp.431~446 (2016)
- Ku JH, "The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy", Br J Cancer, 112, pp.461~467 (2015)
- Huang SH, "Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status", Cancer, 121, pp.545~555 (2015)
- Perisanidis C, "Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors : a systematic review and meta-analysis", Cancer Treat Rev, 41, pp.960~970 (2015)
- Mei Z, "Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors : a systematic review and metaanalysis of 66 cohort studies", Cancer Treat Rev, 58, pp.1~13 (2017)
- Sierzega M, "Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer", Ann Surg Oncol, 24, pp.808~815 (2017)
- Tan Z, "A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma : the Fibrinogen", Albumin Ratio, 2017, pp.8, 1025~1029
- Yi-Xin Zou, "Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases", Cancer Research and Treatment, 51(2), pp.664~671 (2019), 대한암학회
- Liu JX, "Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer", Future Oncol, 14, pp.229~239 (2018)
- Stotz M, "The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer", Clin Chem Lab Med, 53, pp.499~506 (2015)
- Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)
- Raucci MG, "Exfoliated black phosphorus promotes in vitro bone regeneration and suppresses osteosarcoma progression through cancer-related inflammation inhibition", ACS Appl Mater Interfaces, 11, pp.9333~9342 (2019)
- Stone ML, "Cellular determinants and therapeutic implications of inflammation in pancreatic cancer", Pharmacol Ther, 201, pp.202~213 (2019)
- Qi Q, "Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer", Pancreatology, 15, pp.145~150 (2015)
- Trinchieri G, "Cancer immunity : lessons from infectious diseases", J Infect Dis, 1, pp.S67~73 (2015)
- Simpson-Haidaris PJ, "Tumors and fibrinogen : the role of fibrinogen as an extracellular matrix protein", Ann N Y Acad Sci, 936, pp.406~425 (2001)
- Zhang F, "Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT", p-mTOR pathway in esophageal squamous cell carcinoma, 2017, pp.143, 2413~2424
- Shu YJ, "Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection : a retrospective and in vitro study", BMC Cancer, 14, pp.566~ (2014)
- Ridker PM, "Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen : a phase IIb randomized, placebocontrolled trial", Circulation, 126, pp.2739~2748 (2012)
- Ataseven B, "Pre-operative serum albumin is associated with postoperative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery", Gynecol Oncol, 138, pp.560~565 (2015)
- Rothschild MA, "Serum albumin", Hepatology, 8, pp.385~401 (1988)
- Bairey O, "Serum albumin level at diagnosis of diffuse large B-cell lymphoma : an important simple prognostic factor", Hematol Oncol, 34, pp.184~192 (2016)
- Antkowiak M, "Prognostic role of albumin, bilirubin, and ALBI scores : analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization", Cancers(Basel), 11, pp.879~ (2019)
- Qi Q, "Hyperfibrinogen is associated with the systemic inflammatory response and predicts poor prognosis in advanced pancreatic cancer", Pancreas, 44, pp.977~982 (2015)
- Li SQ, "Albuminto-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals", Cancer Med, 7, pp.1221~1231 (2018)
- Liang Y, "Prognostic value of the fibrinogen", albumin ratio(FAR)in patients with operable soft tissue sarcoma, 2018, pp.18, 942~